Simultaneous antigen receptor repertoire profiling and single-cell transcriptomics in T and B lymphocytes from limited clinical samples

对有限临床样本中的 T 和 B 淋巴细胞进行同步抗原受体库分析和单细胞转录组学分析

基本信息

  • 批准号:
    9093707
  • 负责人:
  • 金额:
    $ 39.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-06-26 至 2020-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): In the vast majority of vaccine trials, the primary readouts are empirical do not collect information about the immunological determinants of a vaccine's success or failure. In recent years, several vaccine studies have combined high-throughput transcriptomic data with measures of antigenicity. These "systems vaccinology" studies have proven invaluable insight into the determinants of efficacy and antigenicity, and have demonstrated the enormous value in mechanistic studies of human vaccination. However, one area that is particularly understudied is the composition of antigen specific receptors that arise during successful and unsuccessful vaccinations. Collection of antigen-specific clonotype information in clinical vaccine studies would provide valuable data that could be used to accelerate vaccine development. The utility of current methodology for repertoire sequencing for immunological studies has been limited due to several factors (i) high-cost and low-throughput of cloning based assays (ii) most high-throughput assays only provide information on a single gene(typically the H-chain of immunoglobulin or ß-chain for TCRs), or (iii) do not link ag-receptor sequences with immunophenotypic or transcriptomic data. In preliminary work, we have developed a protocol that simultaneously queries the transcriptome and paired antigen receptor sequences in B lymphocytes derived from human bone marrow after flu vaccination using next generation sequencing. The goal of this proposal is to complete development of this combined "-Seq" assay for both B and T cells, including establishment of its limitations and benchmark against contemporary repertoire sequencing techniques.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Edward Bosinger其他文献

Steven Edward Bosinger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Edward Bosinger', 18)}}的其他基金

Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
艾滋病指定恒河猴繁殖群种系免疫球蛋白库的群体基因分型
  • 批准号:
    10641946
  • 财政年份:
    2021
  • 资助金额:
    $ 39.24万
  • 项目类别:
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
艾滋病指定恒河猴繁殖群种系免疫球蛋白库的群体基因分型
  • 批准号:
    10258937
  • 财政年份:
    2021
  • 资助金额:
    $ 39.24万
  • 项目类别:
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
艾滋病指定恒河猴繁殖群种系免疫球蛋白库的群体基因分型
  • 批准号:
    10891040
  • 财政年份:
    2021
  • 资助金额:
    $ 39.24万
  • 项目类别:
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
艾滋病指定恒河猴繁殖群种系免疫球蛋白库的群体基因分型
  • 批准号:
    10400149
  • 财政年份:
    2021
  • 资助金额:
    $ 39.24万
  • 项目类别:
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
使用恒河猴的 DNA/MVA/蛋白质免疫来研究 HIV-1 包膜的背景和蛋白质增强的性质如何塑造遗传和功能抗体景观。
  • 批准号:
    10204930
  • 财政年份:
    2017
  • 资助金额:
    $ 39.24万
  • 项目类别:
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
开发多模式单细胞技术来剖析 HIV 表位特异性
  • 批准号:
    10632020
  • 财政年份:
    2015
  • 资助金额:
    $ 39.24万
  • 项目类别:
Development of multi-modal single-cell technology to dissect epitope specificity to HIV
开发多模式单细胞技术来剖析 HIV 表位特异性
  • 批准号:
    10415029
  • 财政年份:
    2015
  • 资助金额:
    $ 39.24万
  • 项目类别:
Simultaneous antigen receptor repertoire profiling and single-cell transcriptomics in T and B lymphocytes from limited clinical samples
对有限临床样本中的 T 和 B 淋巴细胞进行同步抗原受体库分析和单细胞转录组学分析
  • 批准号:
    8971431
  • 财政年份:
    2015
  • 资助金额:
    $ 39.24万
  • 项目类别:
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: MHC Genetic Typing Core
Yerkes 国家灵长类研究中心 SPF 育种群体的维护:MHC 基因分型核心
  • 批准号:
    10090673
  • 财政年份:
    2002
  • 资助金额:
    $ 39.24万
  • 项目类别:
Core B: Single cell and integrative genomics core
核心 B:单细胞和整合基因组学核心
  • 批准号:
    9893785
  • 财政年份:
  • 资助金额:
    $ 39.24万
  • 项目类别:

相似海外基金

Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
  • 批准号:
    23K06728
  • 财政年份:
    2023
  • 资助金额:
    $ 39.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
  • 批准号:
    MR/W031353/1
  • 财政年份:
    2022
  • 资助金额:
    $ 39.24万
  • 项目类别:
    Research Grant
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
  • 批准号:
    2145853
  • 财政年份:
    2022
  • 资助金额:
    $ 39.24万
  • 项目类别:
    Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
  • 批准号:
    22K06603
  • 财政年份:
    2022
  • 资助金额:
    $ 39.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
  • 批准号:
    10701754
  • 财政年份:
    2022
  • 资助金额:
    $ 39.24万
  • 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
  • 批准号:
    10557760
  • 财政年份:
    2022
  • 资助金额:
    $ 39.24万
  • 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
  • 批准号:
    437200
  • 财政年份:
    2020
  • 资助金额:
    $ 39.24万
  • 项目类别:
    Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
  • 批准号:
    20H03536
  • 财政年份:
    2020
  • 资助金额:
    $ 39.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
  • 批准号:
    10542442
  • 财政年份:
    2020
  • 资助金额:
    $ 39.24万
  • 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
  • 批准号:
    9922602
  • 财政年份:
    2020
  • 资助金额:
    $ 39.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了